Vault-13

Privium Fund Management B.V.

AMSTERDAM, P7 · CIK 1795097 · 13F filing filed 2025-07-30

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$463.5m reported value +20.8% vs Q1 2025
55positions
81.5%in top 10
7 new 24 added 7 reduced 8 sold out vs Q1 2025

Holdings, Q2 2025

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 SPOTIFY TECHNOLOGY S A SHS SPOT SPOT 114,000 $84.8m18.30% 18.30% ReducedShares held: Q3 2024 149.0k, Q4 2024 145.0k, Q1 2025 145.0k, Q2 2025 114.0k -31.0k -31,000 -21.4%
2 TESLA INC COM TSLA TSLA 242,000 $74.7m16.11% 16.11% AddedShares held: Q3 2024 216.0k, Q4 2024 220.0k, Q1 2025 220.0k, Q2 2025 242.0k +22.0k +22,000 10.0%
3 SHOPIFY INC CL A SUB VTG SHS SHOP SHOP 430,000 $49.0m10.57% 10.57% AddedShares held: Q3 2024 415.0k, Q4 2024 415.0k, Q1 2025 415.0k, Q2 2025 430.0k +15.0k +15,000 3.6%
4 PALANTIR TECHNOLOGIES INC CL A PLTR PLTR 350,000 $46.6m10.05% 10.05% ReducedShares held: Q3 2024 475.0k, Q4 2024 370.0k, Q1 2025 360.0k, Q2 2025 350.0k -10.0k -10,000 -2.8%
5 AMAZON COM INC COM AMZN AMZN 149,000 $32.8m7.07% 7.07% AddedShares held: Q3 2024 141.0k, Q4 2024 141.0k, Q1 2025 141.0k, Q2 2025 149.0k +8.0k +8,000 5.7%
6 SEA LTD SPONSORD ADS SE SE 210,000 $32.5m7.01% 7.01% UnchangedShares held: Q3 2024 210.0k, Q4 2024 210.0k, Q1 2025 210.0k, Q2 2025 210.0k
7 COINBASE GLOBAL INC COM CL A COIN COIN 70,000 $24.2m5.22% 5.22% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 70.0k
8 NVIDIA CORPORATION COM NVDA NVDA 81,000 $12.5m2.70% 2.70% AddedShares held: Q3 2024 73.0k, Q4 2024 73.0k, Q1 2025 73.0k, Q2 2025 81.0k +8.0k +8,000 11.0%
9 IONIS PHARMACEUTICALS INC COM IONS IONS 267,594 $10.7m2.31% 2.31% UnchangedShares held: Q3 2024 250.7k, Q4 2024 266.8k, Q1 2025 267.6k, Q2 2025 267.6k
10 PROQR THRAPEUTICS N V SHS EURO PRQR PRQR 4,997,562 $10.0m2.17% 2.17% AddedShares held: Q3 2024 5.6m, Q4 2024 5.0m, Q1 2025 5.0m, Q2 2025 5.0m +11.9k +11,929 0.2%
11 ARROWHEAD PHARMACEUTICALS IN COM ARWR ARWR 612,214 $9.9m2.13% 2.13% ReducedShares held: Q3 2024 333.4k, Q4 2024 380.6k, Q1 2025 629.2k, Q2 2025 612.2k -17.0k -17,000 -2.7%
12 ULTRAGENYX PHARMACEUTICAL IN COM RARE RARE 253,304 $9.2m1.98% 1.98% AddedShares held: Q3 2024 242.5k, Q4 2024 258.4k, Q1 2025 249.8k, Q2 2025 253.3k +3.5k +3,500 1.4%
13 UNIQURE NV SHS QURE QURE 447,486 $6.3m1.35% 1.35% ReducedShares held: Q3 2024 744.9k, Q4 2024 742.2k, Q1 2025 579.1k, Q2 2025 447.5k -131.7k -131,653 -22.7%
14 AXSOME THERAPEUTICS INC COM AXSM AXSM 52,732 $5.4m1.17% 1.17% UnchangedShares held: Q3 2024 80.2k, Q4 2024 62.2k, Q1 2025 52.7k, Q2 2025 52.7k
15 MERCK & CO INC COM MRK MRK 59,093 $4.8m1.04% 1.04% AddedShares held: Q3 2024 60.1k, Q4 2024 72.6k, Q1 2025 41.1k, Q2 2025 59.1k +18.0k +18,000 43.8%
16 ARCUTIS BIOTHERAPEUTICS INC COM ARQT ARQT 344,472 $4.7m1.02% 1.02% AddedShares held: Q3 2024 0, Q4 2024 325.7k, Q1 2025 325.7k, Q2 2025 344.5k +18.8k +18,763 5.8%
17 ZAI LAB LTD ADR ZLAB ZLAB 132,189 $4.6m1.00% 1.00% UnchangedShares held: Q3 2024 215.6k, Q4 2024 185.1k, Q1 2025 132.2k, Q2 2025 132.2k
18 VERTEX PHARMACEUTICALS INC COM VRTX VRTX 8,300 $3.8m0.81% 0.81% UnchangedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 8.3k, Q2 2025 8.3k
19 ACADIA PHARMACEUTICALS INC COM ACAD ACAD 148,400 $3.2m0.68% 0.68% UnchangedShares held: Q3 2024 148.4k, Q4 2024 148.4k, Q1 2025 148.4k, Q2 2025 148.4k
20 MODERNA INC COM MRNA MRNA 103,433 $3.0m0.64% 0.64% AddedShares held: Q3 2024 40.5k, Q4 2024 82.5k, Q1 2025 75.6k, Q2 2025 103.4k +27.9k +27,857 36.9%
21 BIOGEN INC COM BIIB BIIB 20,500 $2.7m0.58% 0.58% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 20.5k
22 CRISPR THERAPEUTICS AG NAMEN AKT CRSP CRSP 44,700 $2.2m0.47% 0.47% ReducedShares held: Q3 2024 30.3k, Q4 2024 35.0k, Q1 2025 60.1k, Q2 2025 44.7k -15.4k -15,397 -25.6%
23 AMBEV SA SPONSORED ADR ABEV ABEV 795,786 $1.9m0.42% 0.42% ReducedShares held: Q3 2024 622.3k, Q4 2024 652.4k, Q1 2025 804.2k, Q2 2025 795.8k -8.4k -8,420 -1.1%
24 CARVANA CO CL A CVNA CVNA 5,000 $1.7m0.36% 0.36% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 5.0k
25 UROGEN PHARMA LTD COM URGN URGN 107,622 $1.4m0.30% 0.30% UnchangedShares held: Q3 2024 0, Q4 2024 27.7k, Q1 2025 107.6k, Q2 2025 107.6k
26 ROIVANT SCIENCES LTD SHS ROIV ROIV 126,923 $1.4m0.30% 0.30% UnchangedShares held: Q3 2024 484.5k, Q4 2024 215.5k, Q1 2025 126.9k, Q2 2025 126.9k
27 AVIDITY BIOSCIENCES INC COM RNA RNA 46,000 $1.3m0.28% 0.28% AddedShares held: Q3 2024 25.6k, Q4 2024 31.9k, Q1 2025 34.5k, Q2 2025 46.0k +11.5k +11,500 33.3%
28 KRYSTAL BIOTECH INC COM KRYS KRYS 9,320 $1.3m0.28% 0.28% AddedShares held: Q3 2024 6.3k, Q4 2024 9.2k, Q1 2025 7.5k, Q2 2025 9.3k +1.8k +1,810 24.1%
29 BIONTECH SE SPONSORED ADS BNTX BNTX 10,987 $1.2m0.25% 0.25% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 11.0k
30 ROCKET PHARMACEUTICALS INC COM RCKT RCKT 432,760 $1.1m0.24% 0.24% UnchangedShares held: Q3 2024 294.8k, Q4 2024 397.6k, Q1 2025 432.8k, Q2 2025 432.8k
31 HIMS & HERS HEALTH INC COM CL A HIMS HIMS 22,000 $1.1m0.24% 0.24% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 22.0k
32 MEIRAGTX HLDGS PLC COM MGTX MGTX 163,000 $1.1m0.23% 0.23% AddedShares held: Q3 2024 214.0k, Q4 2024 225.1k, Q1 2025 117.0k, Q2 2025 163.0k +46.0k +46,000 39.3%
33 PFIZER INC COM PFE PFE 37,029 $927.2k0.20% 0.20% AddedShares held: Q3 2024 22.0k, Q4 2024 22.0k, Q1 2025 32.3k, Q2 2025 37.0k +4.7k +4,702 14.6%
34 WAVE LIFE SCIENCES LTD SHS 96663EUR 96663EUR 135,550 $883.8k0.19% 0.19% AddedShares held: Q3 2024 48.8k, Q4 2024 88.0k, Q1 2025 113.5k, Q2 2025 135.6k +22.0k +22,000 19.4%
35 PAN AMERN SILVER CORP COM PAAS PAAS 29,747 $844.8k0.18% 0.18% AddedShares held: Q3 2024 26.5k, Q4 2024 21.3k, Q1 2025 21.3k, Q2 2025 29.7k +8.5k +8,463 39.8%
36 NOV INC COM NOV NOV 63,876 $825.3k0.18% 0.18% AddedShares held: Q3 2024 37.9k, Q4 2024 42.9k, Q1 2025 49.7k, Q2 2025 63.9k +14.1k +14,131 28.4%
37 4D MOLECULAR THERAPEUTICS IN COM FDMT FDMT 197,458 $819.5k0.18% 0.18% AddedShares held: Q3 2024 98.5k, Q4 2024 121.0k, Q1 2025 131.0k, Q2 2025 197.5k +66.5k +66,458 50.7%
38 SPROTT FDS TR URANIUM MINERS E URNM URNM 16,278 $761.2k0.16% 0.16% AddedShares held: Q3 2024 8.9k, Q4 2024 10.3k, Q1 2025 12.1k, Q2 2025 16.3k +4.2k +4,164 34.4%
39 LEXEO THERAPEUTICS INC COM LXEO LXEO 178,356 $752.7k0.16% 0.16% AddedShares held: Q3 2024 0, Q4 2024 138.1k, Q1 2025 160.2k, Q2 2025 178.4k +18.2k +18,158 11.3%
40 VIZSLA SILVER CORP COM NEW VZLA VZLA 250,790 $732.3k0.16% 0.16% AddedShares held: Q3 2024 116.5k, Q4 2024 116.5k, Q1 2025 192.5k, Q2 2025 250.8k +58.3k +58,303 30.3%
41 SAREPTA THERAPEUTICS INC COM SRPT SRPT 39,400 $697.8k0.15% 0.15% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 39.4k
42 AUTOLUS THERAPEUTICS PLC SPON ADS AUTL AUTL 294,142 $673.6k0.15% 0.15% AddedShares held: Q3 2024 185.6k, Q4 2024 231.7k, Q1 2025 251.7k, Q2 2025 294.1k +42.5k +42,468 16.9%
43 SEABRIDGE GOLD INC COM COM 44,074 $648.3k0.14% 0.14% UnchangedShares held: Q3 2024 32.1k, Q4 2024 36.0k, Q1 2025 44.1k, Q2 2025 44.1k
44 RECURSION PHARMACEUTICALS IN CL A RXRX RXRX 119,000 $610.5k0.13% 0.13% UnchangedShares held: Q3 2024 78.0k, Q4 2024 119.0k, Q1 2025 119.0k, Q2 2025 119.0k
45 VALARIS LTD CL A VAL VAL 13,803 $606.0k0.13% 0.13% ReducedShares held: Q3 2024 7.6k, Q4 2024 14.2k, Q1 2025 20.2k, Q2 2025 13.8k -6.4k -6,419 -31.7%
46 EMX RTY CORP COM EMX EMX 216,968 $544.6k0.12% 0.12% UnchangedShares held: Q3 2024 0, Q4 2024 217.0k, Q1 2025 217.0k, Q2 2025 217.0k
47 SANDRIDGE ENERGY INC COM NEW SD SD 37,022 $400.9k0.09% 0.09% AddedShares held: Q3 2024 23.3k, Q4 2024 23.3k, Q1 2025 23.3k, Q2 2025 37.0k +13.7k +13,722 58.9%
48 NOBLE CORP PLC ORD SHS A NE NE 14,287 $392.0k0.08% 0.08% UnchangedShares held: Q3 2024 10.5k, Q4 2024 10.5k, Q1 2025 14.3k, Q2 2025 14.3k
49 TAYSHA GENE THERAPIES INC COM SHS TSHA TSHA 134,900 $315.7k0.07% 0.07% UnchangedShares held: Q3 2024 120.0k, Q4 2024 134.9k, Q1 2025 134.9k, Q2 2025 134.9k
50 TIDEWATER INC NEW COM TDW TDW 5,350 $255.2k0.06% 0.06% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 5.3k
51 SIBANYE STILLWATER LTD SPONSORED ADR SBSW SBSW 34,040 $247.8k0.05% 0.05% UnchangedShares held: Q3 2024 34.0k, Q4 2024 34.0k, Q1 2025 34.0k, Q2 2025 34.0k
52 DYNE THERAPEUTICS INC COM DYN DYN 27,566 $239.3k0.05% 0.05% UnchangedShares held: Q3 2024 15.0k, Q4 2024 20.4k, Q1 2025 27.6k, Q2 2025 27.6k
53 ALX ONCOLOGY HLDGS INC COM ALXO ALXO 509,059 $220.6k0.05% 0.05% UnchangedShares held: Q3 2024 509.1k, Q4 2024 509.1k, Q1 2025 509.1k, Q2 2025 509.1k
54 FATE THERAPEUTICS INC COM FATE FATE 111,090 $126.6k0.03% 0.03% AddedShares held: Q3 2024 50.0k, Q4 2024 87.0k, Q1 2025 109.0k, Q2 2025 111.1k +2.1k +2,064 1.9%
55 VOYAGER THERAPEUTICS INC COM VYGR VYGR 25,241 $78.8k0.02% 0.02% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 21.6k, Q2 2025 25.2k +3.6k +3,596 16.6%

Sold out since Q1 2025

SecurityTickerShares held beforeValue then
SNOWFLAKE INC SNOW SNOW 48,000 $7.1m48.0k shares
CLOUDFLARE INC NET NET 60,000 $6.8m60.0k shares
SPRINGWORKS THERAPEUTICS INC SWTX SWTX 123,980 $5.5m124.0k shares
COUPANG INC CPNG CPNG 81,900 $1.8m81.9k shares
ALNYLAM PHARMACEUTICALS INC ALNY ALNY 5,716 $1.5m5.7k shares
IMMUNOVANT INC IMVT IMVT 72,000 $1.2m72.0k shares
AMERICAN INTL GROUP INC AIG AIG 6,483 $563.6k6.5k shares
INTELLIA THERAPEUTICS INC NTLA NTLA 58,709 $417.4k58.7k shares

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
PROQR THRAPEUTICS N V PRQR · 13G · filed 2026-07-15 PRQR 5.2%≈ $10.3m no change 13G 2026-07-15